The transformation of somatic cells into induced pluripotent stem cells (iPSCs) using exogenous factors 1,2 also termed reprogramming, may be used for personalized regenerative medicine and can produce valuable in vitro models of human diseases or be used for toxicology screening. 3, 4 Human iPSCs have been generated from multiple sources including skin (fibroblasts and keratinocytes), extraembryonic tissues or cord blood. 1, 2, [5] [6] [7] [8] [9] The reprogramming from these tissues has been achieved with varied frequencies, indicating that the cells of origin are an important determining factor. Researchers now also argue that iPSCs may retain cell-oforigin epigenetic memory 10 and accumulate other abnormalities as well. 11, 12 Determining all of the cell types that iPSCs can be derived from, and defining their advantages or disadvantages, is therefore important. The ideal cell source should be easily accessible, susceptible, and universal (any age, sex, ethnic group, and body condition). The former consideration excludes many cell types used so far, whereas the latter eliminates neonatal tissues as in most countries they are not routinely stored. Dermal fibroblasts are possibly the most frequent cell type used for reprogramming. Yet, this requires biopsy, which sometimes encourages candidates to refuse donating tissue. Additionally, the procedure is contraindicated in lifethreatening skin diseases (e.g., severe epidermolysis bullosa) or burns. Recently, three groups reported the reprogramming of peripheral blood cells without CD34 ϩ cell mobilization. [13] [14] [15] The procedure is minimally invasive and requires small blood quantity. However, the efficiency was low (0.0008 to 0.1%) and the main target is mature T cells bearing specific T cell receptor rear- rangements, thus representing a caveat for some potential applications. Moreover, in rare cases giving/transfusing blood is not exempt of concerns (e.g., because of religious beliefs), and the reprogramming may be problematic in patients with blood diseases (e.g., hemophilia and leukemia) or immunodepression (e.g., cancer and AIDS). In our search for optimal tissue sources, we have produced human iPSCs from periosteal membrane, adipose stem cells, and extraembryonic tissues. 8, 9 Here we report the generation of iPSCs from exfoliated renal tubular cells present in urine.
The human kidney contains an extensive network of tubules whose total surface is bigger than the skin. As part of normal physiology approximately 2000 to 7000 cells from this tubular system and downstream parts of the urinary tract (ureters, bladder, and urethra) detach and are excreted in urine daily. 16 These cells-hereafter termed urine cells--not only are not damaged but are fully functional and can be used for in vitro studies. 17 Besides, they can be collected anywhere without medical assistance and are easily expanded ( Figure 1A ). We hypothesized that if amenable to reprogramming, urine cells might be a valuable cell source that has some advantages compared with other cell types. We produced cell cultures from urine of several healthy individuals (Table 1) . At first glance they consisted of squamous cells (likely from urethra) and a few blood cells (mostly erythrocytes), but after 3 to 6 days they were replaced by small colonies that grew quickly. These colonies corresponded to two main morphologies: type 1 or type 2 ( Figure 1B ), in agreement with previous reports on urine cell isolation. 18 Type 1 cells were more rounded and grew closely attached to neighbor cells, suggesting an epithelial phenotype. Type 2 cells were more elongated and grew more dispersed. In some sample collections all colonies corresponded to 1 of the 2 cell types, but in others they were mixed. The cell cultures were pooled upon reaching high density and split for further characterization and reprogramming. Those enriched in type 1 cells displayed well formed cell-cell junctions as assessed by immunofluorescence microscopy ( Figure 1C ). They were also positive for the intermediate filament keratin 7 (an epithelial marker) plus the renal proximal tubule marker CD13, and the distribution of actin was cortical ( Figure 1C ). Quantitative realtime PCR (qPCR) further supported a predominant epithelial origin ( Figure  1D ). Renal proximal epithelial cells and fibroblasts were used as controls for the immunofluorescence and qPCR. Type 2 cell-enriched cultures showed a rather similar immunofluorescence pattern, but the intensity was milder, and the distribution more patchy (data not shown); qPCR results were likewise comparable ( Figure 1, C and D) . In both cases we observed little staining for the fibroblastic-like markers fibronectin and vimentin ( Figure 1C) . Therefore, these results support that both cell types have epithelial origin and suggest that type 2 cells may arise from partial epithelial dedifferentiation.
We infected urine cells at passage 2 to 3 with retroviruses producing Sox2, Klf4, Oct4, and c-Myc (Figure 2A ). Infection efficiency was high as shown by parallel transduction with retroviruses producing green fluore2scent protein (GFP), and in cells expressing the factors, we observed early morphology changes indicative of reprogramming 19 ( Figure 2B ). In total, samples from 12 young adults of either Chinese or Caucasian origin were reprogrammed to iPSCs, 7 corresponding to males and 5 to females. Characterization of the primary culture and the resulting iPSCs (hereafter named UiPSCs) is summarized in Table 1 . Small colonies normally appeared at day 11 to 16 posttransduction (Figure 2, A and C) , sometimes later. Many of these colonies progressively adopted human embryonic stem cell (ESC)-like morphology and were picked between days 16 and 25 (Figure 2, A and C) . The reprogramming efficiency varied among donors, but in general was high, between 0.1 and 4% (Table 1) . We produced UiPSCs from a 65-year-old woman as well, but the efficiency was approximately 0.01% (Table  1) . Moreover, we could freeze and thaw urine cells from several donors before transduction without impairing reprogramming efficiency significantly. Urine cells could also be infected at later passages albeit with a drop in efficiency (e.g., 0.3% for passage 5 compared with 3% for passage 2 using donor ZGZ0816 or 0.05% for passage 4 compared with 0.3% for passage 2 using donor UCC0406). After colony expansion ( Figure 2C , bottom), UiPSCs were characterized by standard procedures including alkaline phosphatase staining (AP) (Figure 2C in all cases (Table S1A) . If the circumstances were such, the latter excludes the unlikely contamination and reprogramming of cells from a sexual partner. To prove that these UiPSCs are pluripotent we performed nonspecific differentiation through teratomas ( Figure 3A ) and embryoid bodies (EBs) ( Figure 3B and Supplemental Figure S1A ). Next we did directed-UiPSC differentiation into neural lineages (neural stem cell-like cells, neuron-like cells, and astrocytelike cells) ( Figure 3C) ; hepatocyte-like cells ( Figure 3D and Supplemental Figure S1B) ; and cardiomyocyte-like cells ( Figure 3E and Supplemental Figure  S1C ), which was verified by immunofluorescence microscopy for the appropriate markers and qPCR (for the hepatocytes and cardiomyocytes). Neural differentiation was produced for 12 UiPSCs corresponding to 11 donors, hepatocytes for four clones of three donors, and cardiomyocytes for 14 clones of 11 donors (Table 1) . During cardiomyocyte differentiation the proportion of spontaneously beating EBs was high (between 30 and 75%); a representative recording is included in Supplemental Video S1. Likewise, electrophysiology measurement of action potentials and calcium transients (Figure 3, F through I) showed behavior similar to that of cardiomyocytes produced from human ESCs or fibroblast-derived iPSCs (data not shown).
In conclusion, we have generated iPSCs from an easily accessible source in a totally noninvasive manner, and the quality of our cell lines seems excellent according to standard criteria. It may be arguable to say that urine collection is easier than a skin biopsy or a blood draw in healthy individuals. However, in at least some circumstances (except when there is renal insufficiency) the procedure seems advantageous operationally. It will be relevant to see whether-due to less direct exposure to radiation-urine cells produce iPSCs bearing less somatic cell mutations and copy number variations than iPSCs from skin. 11, 12 Moreover, if it is true that iPSCs have memory of the donor tissue, 10 then one could say that UiPSCs should be the best source for producing renal cells 20 that can be used for transplantation or disease modeling. Collecting urine for creating UiPSCs may be as well an interesting option for certain genetic diseases (e.g., von HippelLindau syndrome) 21 in which the remaining wild-type allele is mainly mutated in the kidney. Clearly, nonintegration and mouse feeder-free approaches would be required to ultimately produce clinical grade iPSCs, 22, 23 but it is likely that such approaches can be applied to urine cells. Caveats such as lack of the strictest sterility are a concern not only during urine collection but for any ex vivo cell source and do not represent a technical obstacle for UiPSC generation provided that some basic norms of hygiene are taken and antibiotics included in the early stages of culture. In fact urine is sterile before it reaches the urethra, and we only collect the middle stream of the micturition. Therefore, in at least some situations urine samples may be considered a preferred source for iPSC derivation.
CONCISE METHODS
The collection and culture of urine cells is described in detail in the Supplemental Methods. The ethics committee of the Guangzhou Institutes of Biomedicine and Health (in Guangzhou, China) or the University of Natural Resources and Life Sciences (in Vienna, Austria) approved this and other procedures, and signed consent forms are available upon request. Skin fibroblasts were purchased from Coriell cell repository (AG06299) and maintained in DMEM (Invitrogen) ϩ 10% (vol/vol) FBS (Hyclone). Retroviral plasmids producing human Oct4, Sox2, Klf4, and c-Myc transcription factors were purchased from Addgene. Viral supernatants were harvested on 2 consecutive days starting 48 hours after transfection. Urine cells at passages 2 to 4 were trypsinized and seeded on six-well dishes, and 60,000 cells were added per well. Cells were infected with viral supernatants generated by transfection of HEK293T cells (using Lipofectamine 2000, Invitrogen) with retroviral pMXs vectors (Addgene) containing the cDNAs of human Oct4, Sox2, Klf4, and cMyc. Two rounds of infection were performed successively (of 12 hours each) as described before. 7 Polybrene (Sigma) was added to increase infection efficiency. After the second round of infection the tissue culture medium of the transduced cells was changed to urine cell medium. Infection efficiency was monitored separately and was close to 100% as demonstrated by transduction with GFP-expressing vectors. On day 3 or 4, cells transduced with the reprogramming factors were trypsinized, and their number was counted. Routinely, 50,000 cells were seeded onto a layer of feeders in a 10-cm culture dish, using human ESC medium (F12 ϩ 20% Knock-out Serum Replacement ϩ 10 ng/ml basic fibroblast growth factor ϩ nonessential amino acids [all from Invitrogen], L-glutamine, and ␤-mercaptoethanol, which was renewed daily. On day 5, the medium was changed to human ESC medium ϩ 1 mM valproic acid (VPA; Sigma) or half ESC mediumϩ half dFBS medium (consisting of DMEM high glucose [Invitrogen] ϩ 20% human defined fetal bovine serum [dFBS, Hyclone] ϩ VPA. In both cases VPA was added only from day 5 to 12. From day 12 to day 16 we used human ESC medium and then mTesR1 medium (StemCell) until the last day of the experiment. After infection the medium was renewed daily in all stages. From day 16, those colonies that were big enough and identifiable as human ESC-like (i.e., flat morphology with defined borders and big nuclei containing prominent nucleoli), could be picked mechanically and expanded in human ESC medium on feeders or on mTesR1 medium on Matrigel. Details of UiPSC characterization procedures are also provided in Supplemental Methods. 
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